Nihel Khoudour Selected Research

Sepsis (Septicemia)

1/2022

Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nihel Khoudour Research Topics

Disease

5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2019
3	Neoplasms (Cancer) 05/2021 - 01/2021
2	Vasculitis (Vasculitides) 11/2023 - 03/2021
2	Critical Illness (Critically Ill) 01/2022 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023
1	Cushing Syndrome 05/2023
1	Infections 01/2023
1	Cardiotoxicity 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 06/2022
1	Poisoning 03/2022
1	Paralysis (Palsy) 03/2022
1	Sepsis (Septicemia) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 08/2021
1	Fibrosarcoma 01/2021
1	Melanoma (Melanoma, Malignant) 04/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2017

Drug/Important Bio-Agent (IBA)

3	NivolumabIBA 03/2021 - 11/2019
2	Rituximab (Mabthera)FDA Link 11/2023 - 03/2021
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2016
2	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 03/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2023
1	OsilodrostatIBA 05/2023
1	Metyrapone FDA Link 05/2023
1	CrizotinibIBA 01/2023
1	SofosbuvirIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	velpatasvirIBA 01/2023
1	osimertinibIBA 09/2022
1	pazopanib FDA Link 06/2022
1	Angiogenesis InhibitorsIBA 06/2022
1	Serotonin (5 Hydroxytryptamine)IBA 03/2022
1	Cyproheptadine (Periactin)FDA Link 03/2022
1	Tramadol (K315)FDA LinkGeneric 03/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	olaparibIBA 08/2021
1	pembrolizumabIBA 05/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	dabrafenibIBA 04/2020
1	trametinibIBA 04/2020
1	LigandsIBA 02/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	CD40 Ligand (CD40L)IBA 02/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	enzalutamideIBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2017
1	Atovaquone (Mepron)FDA Link 01/2017
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017

Therapy/Procedure

3	Therapeutics 11/2023 - 02/2020
1	Extracorporeal Membrane Oxygenation 01/2022
1	Castration 01/2020